Latest Insider Transactions at Medpace Holdings, Inc. (MEDP)
This section provides a real-time view of insider transactions for Medpace Holdings, Inc. (MEDP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medpace Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medpace Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
58,681
-0.91%
|
$12,909,820
$220.46 P/Share
|
|
Jun 06
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
58,681
-0.91%
|
$12,909,820
$220.46 P/Share
|
|
Apr 25
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
31,648
-0.49%
|
$6,994,208
$221.83 P/Share
|
|
Apr 25
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
31,648
-0.49%
|
$6,994,208
$221.83 P/Share
|
|
Mar 31
2023
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
104
+50.0%
|
-
|
|
Mar 31
2023
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
82
+50.0%
|
-
|
|
Mar 31
2023
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
94
+50.0%
|
-
|
|
Nov 16
2022
|
Kevin M. Brady CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
344
-10.29%
|
$78,088
$227.09 P/Share
|
|
Nov 15
2022
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
7,000
-52.31%
|
$1,610,000
$230.0 P/Share
|
|
Nov 15
2022
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+34.34%
|
$196,000
$28.32 P/Share
|
|
Nov 15
2022
|
Kevin M. Brady CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
1,656
-33.12%
|
$379,224
$229.3 P/Share
|
|
Nov 01
2022
|
Robert O. Kraft Director |
SELL
Open market or private sale
|
Direct |
9,630
-100.0%
|
$2,128,230
$221.42 P/Share
|
|
Nov 01
2022
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,630
+50.0%
|
$221,490
$23.0 P/Share
|
|
Oct 27
2022
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
6,500
-30.44%
|
$1,430,000
$220.53 P/Share
|
|
Oct 27
2022
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+23.34%
|
$208,000
$32.05 P/Share
|
|
Sep 22
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
57,426
+0.88%
|
$8,843,604
$154.59 P/Share
|
|
Sep 22
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
57,426
+0.88%
|
$8,843,604
$154.59 P/Share
|
|
Sep 21
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
94,119
+1.44%
|
$15,153,159
$161.63 P/Share
|
|
Sep 21
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
94,119
+1.44%
|
$15,153,159
$161.63 P/Share
|
|
Sep 20
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
94,119
+1.46%
|
$14,588,445
$155.14 P/Share
|
|
Sep 20
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
94,119
+1.46%
|
$14,588,445
$155.14 P/Share
|
|
Sep 19
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
94,119
+1.49%
|
$14,400,207
$153.48 P/Share
|
|
Sep 19
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
94,119
+1.49%
|
$14,400,207
$153.48 P/Share
|
|
Sep 16
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,516
+1.01%
|
$9,314,884
$149.58 P/Share
|
|
Sep 16
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
62,516
+1.01%
|
$9,314,884
$149.58 P/Share
|
|
Sep 15
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
62,516
+1.02%
|
$9,564,948
$153.11 P/Share
|
|
Sep 15
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,516
+1.02%
|
$9,564,948
$153.11 P/Share
|
|
Sep 14
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
62,516
+1.03%
|
$9,502,432
$152.66 P/Share
|
|
Sep 14
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,516
+1.03%
|
$9,502,432
$152.66 P/Share
|
|
Sep 13
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
62,516
+1.04%
|
$9,815,012
$157.12 P/Share
|
|
Sep 13
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,516
+1.04%
|
$9,815,012
$157.12 P/Share
|
|
Sep 12
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
62,515
+1.05%
|
$10,440,005
$167.58 P/Share
|
|
Sep 12
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,515
+1.05%
|
$10,440,005
$167.58 P/Share
|
|
Sep 09
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
56,557
+0.96%
|
$9,275,348
$164.33 P/Share
|
|
Sep 09
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
56,557
+0.96%
|
$9,275,348
$164.33 P/Share
|
|
Sep 08
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
56,557
+0.97%
|
$8,879,449
$157.65 P/Share
|
|
Sep 08
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
56,557
+0.97%
|
$8,879,449
$157.65 P/Share
|
|
Sep 07
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
56,557
+0.98%
|
$8,483,550
$150.72 P/Share
|
|
Sep 07
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
56,557
+0.98%
|
$8,483,550
$150.72 P/Share
|
|
Sep 06
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
56,557
+0.99%
|
$8,313,879
$147.59 P/Share
|
|
Sep 06
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
56,557
+0.99%
|
$8,313,879
$147.59 P/Share
|
|
Sep 02
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
48,714
+0.86%
|
$7,014,816
$144.98 P/Share
|
|
Sep 02
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
48,714
+0.86%
|
$7,014,816
$144.98 P/Share
|
|
Sep 01
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
42,076
+0.75%
|
$6,058,944
$144.52 P/Share
|
|
Sep 01
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
42,076
+0.75%
|
$6,058,944
$144.52 P/Share
|
|
Jul 18
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
8,330
+0.15%
|
$1,207,850
$145.0 P/Share
|
|
Jul 18
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,330
+0.15%
|
$1,207,850
$145.0 P/Share
|
|
Jul 14
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
22,290
+0.4%
|
$3,209,760
$144.59 P/Share
|
|
Jul 14
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
22,290
+0.4%
|
$3,209,760
$144.59 P/Share
|
|
May 06
2022
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.31%
|
$32,000
$32.05 P/Share
|